Viewing Study NCT01083368


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-01-07 @ 7:36 AM
Study NCT ID: NCT01083368
Status: COMPLETED
Last Update Posted: 2019-08-21
First Post: 2010-03-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
Sponsor: Case Comprehensive Cancer Center
Organization: